Slim pickings for two weight-loss drugs?

Many medications for weight loss have been proposed or are under development. The Federal Drug Administration has approved few drugs for long-term weight loss, and some are no longer marketed because of safety issues, researchers of a new study have reported. In 2012, though, the FDA approved two drugs for long-term weight loss, lorcaserin hydrochloride (Belviq; Eisai Inc) and phentermine/topiramate (Qsymia; Vivus Inc). But Dartmouth researchers question how safe these two drugs are based on the FDA approval after one-year trials?
Source: ScienceDaily Headlines - Category: Science Source Type: news

Related Links:

CONCLUSION: Knowledge of risk factors would allow implementation of secondary or tertiary preventive devices. Students could undergo early screening of psychiatric pathologies using mobile screening teams which would save money, avoid hospitalizations, and when necessary, facilitate both hospitalization and return visits. PMID: 31113536 [PubMed - as supplied by publisher]
Source: L Encephale - Category: Psychiatry Tags: Encephale Source Type: research
Publication date: Available online 23 May 2019Source: Journal of Taibah University Medical SciencesAuthor(s): Mothanna K. AlRahabi, Hani M. Ghabbaniالملخصتُظهر ضواحك الفك العلوي اختلافات تشريحية في أعداد الجذور والقنوات، ويشكل ذلك تحديا خلال علاج قناة الجذر. في تقرير الحالة هذا، نصف معالجة ضاحك الفك العلوي ذي ثلاثة جذور. أُحيل مريض يمني عمره ٤٧ عاما إلى كلية طب الأسنان بجامعة طيبة للمعالجة اللبية للضاحك العلو...
Source: Journal of Taibah University Medical Sciences - Category: Universities & Medical Training Source Type: research
Publication date: June 2019Source: The American Journal of Surgery, Volume 217, Issue 6Author(s):
Source: The American Journal of Surgery - Category: Surgery Source Type: research
Publication date: June 2019Source: The American Journal of Surgery, Volume 217, Issue 6Author(s):
Source: The American Journal of Surgery - Category: Surgery Source Type: research
Publication date: June 2019Source: The American Journal of Surgery, Volume 217, Issue 6Author(s):
Source: The American Journal of Surgery - Category: Surgery Source Type: research
ConclusionsThe present meta-analysis of randomized controlled trials investigating the value of PD following colorectal anastomoses does not support the routine use of prophylactic drains.Graphical abstract
Source: The American Journal of Surgery - Category: Surgery Source Type: research
Publication date: Available online 22 May 2019Source: The American Journal of SurgeryAuthor(s): Leila Mounesan, Siamak Sabour
Source: The American Journal of Surgery - Category: Surgery Source Type: research
Publication date: Available online 23 May 2019Source: Journal of Visceral SurgeryAuthor(s): P. Infantes, M. Mezzadri, R. Lo Dico
Source: Journal of Visceral Surgery - Category: Surgery Source Type: research
ConclusionLLR for HCC after FP is safe and feasible, and might be considered an alternative treatment of HCC for which the best treatment has not been defined yet.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
CONCLUSIONThe surgical approach with major cytoreductive purposes could improve the prognosis in cases with prevalent abdominal extranodal localisation.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
More News: Adipex | Phentermine | Science | Study | Topamax | Weight Loss